about
The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII.Failure of recombinant factor VIIa in a patient with severe polymicrobial sepsis and postoperative uncontrolled intraabdominal bleeding.Recombinant activated factor VII in controlling bleeding in non-hemophiliac patientsContinuous infusion of coagulation factors.The pharmacokinetics of clotting factor therapy.Manipulation of the membrane binding site of vitamin K-dependent proteins: enhanced biological function of human factor VII.Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patientsCritical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors
P2860
Q30833127-7CB0C2BF-739D-44D3-8112-FDFC53654741Q33282917-BAF63F5C-210D-482E-AE9E-9EC9E579D040Q33918017-9E46A154-7B61-402F-807B-CDBAF98C69C4Q34636862-28A7BBA0-13FC-4C1F-829D-B525486D4AEFQ35163599-F6A8EEBF-CB0C-4DC8-8A88-0FE52AE090A6Q36467427-915DAC0D-9D2F-42CE-804D-C5835CA27141Q36745575-081B1510-7780-4DAD-B45A-991B267A8554Q40539842-B938B5C7-B730-4330-BF29-7A8F0E44DAF7
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Dosing and monitoring NovoSeven treatment.
@en
Dosing and monitoring NovoSeven treatment.
@nl
type
label
Dosing and monitoring NovoSeven treatment.
@en
Dosing and monitoring NovoSeven treatment.
@nl
prefLabel
Dosing and monitoring NovoSeven treatment.
@en
Dosing and monitoring NovoSeven treatment.
@nl
P356
P1476
Dosing and monitoring NovoSeven treatment.
@en
P2093
P304
P356
10.1159/000217250
P478
26 Suppl 1
P577
1996-01-01T00:00:00Z